Chronic obstructive pulmonary disease, or COPD, caused 141,733 deaths in the United States in 2023—the latest data that has been reported. That number reflects not just the effects of smoking, but a broader set of medical ...
1 hour ago
0
0
A Virginia Tech team has identified a promising new therapeutic strategy for idiopathic pulmonary fibrosis (IPF), showing that blocking two proteins can halt and even reverse lung scarring in pre-clinical models.
7 hours ago
0
1
Vanderbilt researchers led by Xiaoguang Dong, assistant professor of mechanical engineering, have developed a novel device that can be used remotely to continuously monitor the airway stents of patients with diseases like ...
Apr 27, 2026
0
3
Researchers from the University at Buffalo and Roswell Park Comprehensive Cancer Center are developing an artificial intelligence tool to help surgeons better identify lung cancer patients at risk for postoperative complications. ...
Apr 27, 2026
0
3
Wildfire smoke is no longer confined to distant regions. It is increasingly affecting communities throughout the United States, raising urgent questions about air quality, public health, and long-term risk. Researchers at ...
Apr 27, 2026
0
3
In a new study, researchers found that older adults with obesity had significantly decreased measures of lung function compared to those without obesity, and the results were consistent among men and women. These results ...
Apr 27, 2026
0
3
People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked. FIU researchers have now uncovered a previously unknown mechanism that helps explain how HIV causes ...
Apr 25, 2026
0
6
Cystic fibrosis is among the most common, known and studied genetic diseases. It affects over 100,000 people worldwide and reduces life expectancy mainly as it causes lung and respiratory problems. Over the years, scientific ...
Apr 24, 2026
0
6
Ambient air pollution is associated with respiratory infection burden in the first year of life, according to preliminary findings from the Immune Development in Early Life (IDEaL) Rome Cohort. Findings from the cohort were ...
Apr 24, 2026
0
2
The first comparative analysis from the ENGULF (A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device For the Treatment of Pulmonary Embolism) trial shows that using blood return during continuous ...
Apr 24, 2026
0
2
